Cannabicyclol
Cannabicyclol (CBL) is a non-psychoactive cannabinoid found in the Cannabis plant. It is a minor constituent of the plant, and is considered to be a degradative product of cannabichromene (CBC).
Chemistry[edit]
Cannabicyclol is a cannabinoid that is derived from cannabichromene. Exposure to light causes cannabichromene to convert to cannabicyclol. The chemical structure of CBL is similar to other cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabigerol (CBG).
Pharmacology[edit]
The pharmacological effects of CBL are not well-studied. However, like other cannabinoids, it is thought to interact with the endocannabinoid system in the human body. This system is involved in a variety of physiological processes, including pain sensation, mood, and memory.
Research[edit]
Research into the potential therapeutic uses of CBL is limited. However, some studies suggest that it may have anti-inflammatory and anti-tumor effects. More research is needed to fully understand the potential medical applications of CBL.
Legal status[edit]
The legal status of CBL varies by country. In some jurisdictions, it is classified as a controlled substance, while in others it is legal to possess and use.
See also[edit]
